| [1] |
Silberfarb PM. Chemotherapy and cognitive defects in cancer patients[J]. Annu Rev Med,1983,34:35-46.
|
| [2] |
Janelsins MC, Kohli S, Mohile SG, et al. An update on cancer- and chemotherapy-related cognitive dysfunction: current status[J]. Semin Oncol,2011,38(3):431-438.
|
| [3] |
Cheung YT, Tan EH, Chan A. An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors[J]. Support Care Cancer,2012,20(7):1361-1375.
|
| [4] |
de Ruiter MB, Reneman L, Boogerd W, et al. Late effects of highdose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging[J]. Hum Brain Mapp,2012,33(12):2971-2983.
|
| [5] |
Deprez S, Amant F, Smeets A, et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning[J]. J Clin Oncol,2012,30(3):274-281.
|
| [6] |
Kohli S, Fisher SG, Tra Y, et al. The effect of modafinil on cognitive function in breast cancer survivors[J]. Cancer,2009,115(12):2605-2616.
|
| [7] |
施新猷. 医用实验动物学[M]. 西安:陕西科学技术出版社,1989:396-397.
|
| [8] |
Hodgson KD, Hutchinson AD, Wilson CJ, et al. A meta-analysis of the effects of chemotherapy on cognition in patients with cancer [J].Cancer Treat Rev,2013,39(3):297-304.
|
| [9] |
Silverman DH, Dy CJ, Castellon SA, et al. Altered frontocortical,cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy[J]. Breast Cancer Res Treat,2007,103(3):303-311.
|
| [10] |
Calvio L, Peugeot M, Bruns GL, et al. Measures of cognitive function and work in occupationally active breast cancer survivors[J]. J Occup Environ Med,2010,52(2):219-227.
|
| [11] |
Deprez S, Amant F, Yigit R, et al. Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients [J]. Hum Brain Mapp,2011,32(3):480-493.
|
| [12] |
Squire LR, van der Horst AS, Mcduff SG, et al. Role of the hippocampus in remembering the past and imagining the future [J].Proc Natl Acad Sci U S A,2010,107(44):19 044-19 048.
|
| [13] |
Janelsins MC, Roscoe JA, Berg MJ, et al. IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice [J]. Cancer Invest,2010,28(5):544-553.
|
| [14] |
Winocur G, Vardy J, Binns MA, et al. The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice[J]. Pharmacol Biochem Behav,2006,85(1):66-75.
|
| [15] |
Dietrich J. Chemotherapy associated central nervous system damage[J]. Adv Exp Med Biol,2010,678:77-85.
|
| [16] |
Ahles TA,Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes [J]. Nat Rev Cancer,2007,7(3):192-201.
|
| [17] |
Janelsins MC, Mustian KM, Palesh OG, et al. Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research[J].Support Care Cancer,2012,20(4):831-839.
|
| [18] |
Tangpong J, Cole MP, Sultana R, et al. Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity[J]. Neurobiol Dis,2006,23(1):127-139.
|
| [19] |
Joshi G, Aluise CD, Cole MP, et al. Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain [J]. Neuroscience, 2010, 166 (3):796-807.
|
| [20] |
Marsland AL, Gianaros PJ, Abramowitch SM, et al. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults [J]. Biol Psychiatry,2008,64(6):484-490.
|
| [21] |
Mcafoose J, Baune BT. Evidence for a cytokine model of cognitive function [J]. Neurosci Biobehav Rev,2009,33(3):355-366.
|
| [22] |
Konat GW, Kraszpulski M, James I, et al. Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats[J]. Metab Brain Dis,2008,23(3):325-333.
|
| [23] |
Gandal MJ, Ehrlichman RS, Rudnick ND, et al. A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice[J]. Neuroscience,2008,157(1):95-104.
|
| [24] |
Briones TL, Woods J. Dysregulation in myelination mediated by persistent neuroinflammation: possible mechanisms in chemotherapyrelated cognitive impairment [J]. Brain Behav Immun,2014,35:23-32.
|
| [25] |
Mu L, Wang J, Cao B, et al. Impairment of cognitive function by chemotherapy: association with the disruption of phase-locking and synchronization in anterior cingulate cortex [J]. Mol Brain,2015,8:32.
|
| [26] |
Morris R. Developments of a water-maze procedure for studying spatial learning in the rat[J]. J Neurosci Methods,1984,11(1):47-60.
|
| [27] |
Maei HR, Zaslavsky K, Wang AH, et al. Development and validation of a sensitive entropy-based measure for the water maze[J]. Front Integr Neurosci,2009,3:33.
|
| [28] |
D'Hooge R,De Deyn PP. Applications of the Morris water maze in the study of learning and memory[J]. Brain Res Brain Res Rev, 2001,36(1):60-90.
|
| [29] |
Williams MT, Morford LL, Wood SL, et al. Developmental D-methamphetamine treatment selectively induces spatial navigation impairments in reference memory in the Morris water maze while sparing working memory[J]. Synapse,2003,48(3):138-148.
|
| [30] |
Patil SS, Sunyer B, Hoger H, et al. Evaluation of spatial memory of C57BL/6J and CD1 mice in the Barnes maze, the Multiple T-maze and in the Morris water maze[J]. Behav Brain Res,2009,198(1):58-68.
|
| [31] |
Van Dam D, Lenders G, De Deyn PP. Effect of Morris water maze diameter on visual-spatial learning in different mouse strains [J].Neurobiol Learn Mem,2006,85(2):164-172.
|
| [32] |
Zhou SJ, Zhu ME, Shu D, et al. Preferential enhancement of working memory in mice lacking adenosine A(2A) receptors [J]. Brain Res,2009,1303:74-83.
|
| [33] |
Campeau S, Liberzon I, Morilak D, et al. Stress modulation of cognitive and affective processes [J]. Stress,2011,14(5):503-519.
|